Mascha Binder

7.6k total citations · 1 hit paper
136 papers, 2.9k citations indexed

About

Mascha Binder is a scholar working on Oncology, Genetics and Immunology. According to data from OpenAlex, Mascha Binder has authored 136 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Oncology, 31 papers in Genetics and 31 papers in Immunology. Recurrent topics in Mascha Binder's work include Chronic Lymphocytic Leukemia Research (25 papers), Cancer Immunotherapy and Biomarkers (18 papers) and Lymphoma Diagnosis and Treatment (15 papers). Mascha Binder is often cited by papers focused on Chronic Lymphocytic Leukemia Research (25 papers), Cancer Immunotherapy and Biomarkers (18 papers) and Lymphoma Diagnosis and Treatment (15 papers). Mascha Binder collaborates with scholars based in Germany, Switzerland and United States. Mascha Binder's co-authors include Lisa Paschold, Edith Willscher, Christoph Schultheiß, Martin Trepel, Carsten Bokemeyer, Friederike Braig, Magali Noval Rivas, Rebecca A. Porritt, Moshe Arditi and Anna Brandt and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Medicine.

In The Last Decade

Mascha Binder

127 papers receiving 2.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The IL-1β, IL-6, and TNF cytokine triad is associated with post-acute sequelae of COVID-19

2022 256 citations Christoph Schultheiß, Edith Willscher et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mascha Binder Germany	28	866	729	609	585	434	136	2.9k
Yoshihiro Komada Japan	27	585 0.7×	787 1.1×	806 1.3×	197 0.3×	221 0.5×	191	3.0k
Keon Hee Yoo South Korea	32	597 0.7×	968 1.3×	435 0.7×	245 0.4×	540 1.2×	211	3.4k
Rainer Claus Germany	32	614 0.7×	2.6k 3.5×	467 0.8×	371 0.6×	285 0.7×	132	4.1k
Hong Hoe Koo South Korea	34	662 0.8×	1.1k 1.6×	436 0.7×	239 0.4×	575 1.3×	210	3.7k
Kim Vettenranta Finland	31	654 0.8×	571 0.8×	290 0.5×	266 0.5×	192 0.4×	167	3.4k
Daobin Zhou China	28	1.0k 1.2×	633 0.9×	502 0.8×	193 0.3×	890 2.1×	312	3.4k
Robert J. Hayashi United States	30	1.4k 1.6×	604 0.8×	1.4k 2.3×	123 0.2×	320 0.7×	109	4.2k
Dirk Schwabe Germany	30	1.2k 1.4×	683 0.9×	1.4k 2.3×	244 0.4×	440 1.0×	105	3.7k
Manel Juan Spain	36	912 1.1×	827 1.1×	1.7k 2.8×	372 0.6×	88 0.2×	180	4.1k
Ki Woong Sung South Korea	31	598 0.7×	1.3k 1.7×	322 0.5×	198 0.3×	608 1.4×	207	3.6k

Countries citing papers authored by Mascha Binder

Since Specialization

Citations

This map shows the geographic impact of Mascha Binder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mascha Binder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mascha Binder more than expected).

Fields of papers citing papers by Mascha Binder

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mascha Binder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mascha Binder. The network helps show where Mascha Binder may publish in the future.

Co-authorship network of co-authors of Mascha Binder

This figure shows the co-authorship network connecting the top 25 collaborators of Mascha Binder. A scholar is included among the top collaborators of Mascha Binder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mascha Binder. Mascha Binder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zingg, Andreas, Reto Ritschard, Helen Thut, et al.. (2025). Targeting Cancer-Associated Glycosylation for Adoptive T-cell Therapy of Solid Tumors. Cancer Immunology Research. 13(7). 990–1003.

Schmitz, Boris, Christian v. Bar, Shambhabi Chatterjee, et al.. (2025). Autonomic dysfunction and vasoregulation in long COVID-19 are linked to anti-GPCR autoantibodies. Journal of Allergy and Clinical Immunology. 157(3). 722–738.e7.

Paschold, Lisa, Christoph Schultheiß, Konrad Klinghammer, et al.. (2025). Inflammation and limited adaptive immunity predict worse outcomes on immunotherapy in head and neck cancer. npj Precision Oncology. 9(1). 272–272.

Schultheiß, Christoph, Lisa Paschold, Benjamin Thiele, et al.. (2024). T-cell receptor architecture and clonal tiding provide insight into the transformation trajectory of peripheral T-cell lymphomas. Haematologica. 110(2). 457–469. 2 indexed citations

Binder, Mascha, Daniel Sedding, Thomas Frese, et al.. (2024). Differential associations between SARS-CoV-2 infection, perceived burden of the pandemic and mental health in the German population-based cohort for digital health research. Psychiatry Research. 341. 116140–116140.

Brioli, Annamaria, Katia Mancuso, Mascha Binder, et al.. (2023). Pomalidomide combinations are a safe and effective option after daratumumab failure. Journal of Cancer Research and Clinical Oncology. 149(9). 6569–6574. 4 indexed citations

Paschold, Lisa, Thomas Weber, Richard Brill, et al.. (2023). No association of malignant B‐cell non‐Hodgkin lymphomas with ipsilateral SARS‐CoV‐2 vaccination. Cancer Medicine. 12(8). 9313–9321. 1 indexed citations

Brandt, Anna, et al.. (2023). Circulating Tumor DNA in Head and Neck Squamous Cell Carcinoma. Cancers. 15(7). 2051–2051. 5 indexed citations

Gottschick, Cornelia, Bianca Klee, Anja Broda, et al.. (2023). Mental health in Germany in the first weeks of the Russo-Ukrainian war. BJPsych Open. 9(3). e66–e66. 17 indexed citations

10.

Jaekel, Nadja, Robby Engelmann, Frank Bernhard Kraus, et al.. (2022). Longitudinal Humoral and Cellular Immune Responses Following SARS-CoV-2 Vaccination in Patients with Myeloid and Lymphoid Neoplasms Compared to a Reference Cohort: Results of a Prospective Trial of the East German Study Group for Hematology and Oncology (OSHO). Cancers. 14(6). 1544–1544. 4 indexed citations

11.

Schultheiß, Christoph, et al.. (2022). B cells in autoimmune hepatitis: bystanders or central players?. Seminars in Immunopathology. 44(4). 411–427. 16 indexed citations

12.

Porritt, Rebecca A., Lisa Paschold, Magali Noval Rivas, et al.. (2021). HLA class I–associated expansion of TRBV11-2 T cells in multisystem inflammatory syndrome in children. Journal of Clinical Investigation. 131(10). 99 indexed citations

13.

Porritt, Rebecca A., Aleksandra Binek, Lisa Paschold, et al.. (2021). The autoimmune signature of hyperinflammatory multisystem inflammatory syndrome in children. Journal of Clinical Investigation. 131(20). 86 indexed citations

14.

Mehra, Niven, Gosse J. Adema, Linda G.W. Kerkmeijer, et al.. (2021). 642TiP Phase II CA184-585 (INSPIRE) trial of ipilimumab with nivolumab for molecular-selected patients with castration-resistant prostate cancer. Annals of Oncology. 32. S671–S671. 2 indexed citations

15.

Cheng, Mary Hongying, She Zhang, Rebecca A. Porritt, et al.. (2020). Superantigenic character of an insert unique to SARS-CoV-2 spike supported by skewed TCR repertoire in patients with hyperinflammation. Proceedings of the National Academy of Sciences. 117(41). 25254–25262. 206 indexed citations

16.

Mohme, Malte, Cécile L. Maire, Simon Schliffke, et al.. (2020). Local Intracerebral Immunomodulation Using Interleukin-Expressing Mesenchymal Stem Cells in Glioblastoma. Clinical Cancer Research. 26(11). 2626–2639. 30 indexed citations

17.

Tintelnot, Joseph, Christoph Schultheiß, Friederike Braig, et al.. (2019). Nanobody Targeting of Epidermal Growth Factor Receptor (EGFR) Ectodomain Variants Overcomes Resistance to Therapeutic EGFR Antibodies. Molecular Cancer Therapeutics. 18(4). 823–833. 26 indexed citations

18.

Felden, Johann von, Laurent Alric, Sven Pischke, et al.. (2019). The burden of hepatitis E among patients with haematological malignancies: A retrospective European cohort study. Journal of Hepatology. 71(3). 465–472. 62 indexed citations

19.

Mohme, Malte, Simon Schliffke, Cécile L. Maire, et al.. (2018). Immunophenotyping of Newly Diagnosed and Recurrent Glioblastoma Defines Distinct Immune Exhaustion Profiles in Peripheral and Tumor-infiltrating Lymphocytes. Clinical Cancer Research. 24(17). 4187–4200. 109 indexed citations

20.

Binder, Mascha, F.‐Nora Vögtle, Stefan Michelfelder, et al.. (2007). Identification of Their Epitope Reveals the Structural Basis for the Mechanism of Action of the Immunosuppressive Antibodies Basiliximab and Daclizumab. Cancer Research. 67(8). 3518–3523. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact